Ad
related to: the 340b drug pricing programgoodrx.com has been visited by 100K+ users in the past month
A prescription drug card that actually does work - BBB.org
- Phone Support Available
Our dedicated customer support team
is here to help answer questions.
- Do I Need Insurance?
No! Compare Our Prices to Your
Insurance & Get the Biggest Savings
- Research You Can Rely On
Our team works hard to provide you
with the latest healthcare info.
- Free Discount Card
Get a Free Discount Card Today and
Start Saving up to 80% Off Your Rx
- Phone Support Available
Search results
Results from the WOW.Com Content Network
The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. The intent of the program is to allow covered entities to "stretch scarce federal resources as far as possible ...
One of the following programs is the 340B pricing program that allows hospitals and pharmacists to buy drugs at 30–50% off the retail prices. [71] Per HRSA's 340B Drug Pricing Program, drug manufacturers are required to give certain organizations discounted drugs given these organizations fit the eligibility criteria for discounts. [72]
The Program is a federal program. The 340B Drug Pricing Program, administered by the Office of Pharmacy Affairs, resulted from enactment of Public Law 102-585, the Veterans Health Care Act of 1992, which is codified as Section 340B of the Public Health Service Act.
We cannot expand the 340B Program until we can be sure that the program is working to improve health-care access and health equity in New York.
For premium support please call: 800-290-4726 more ways to reach us
A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law requiring pharmaceutical companies to negotiate drug prices with the ...
Pharmaceutical companies are legally required to pay for a portion of the medications used by critical access hospitals as part of the 340B Drug Pricing Program. Few CAHs provide intensive care treatment. A review of CAHs in the early 2000s counted 26% of the hospitals providing intensive care-level treatment to at least one patient.
The 340B Drug Pricing Program is a U.S. federal program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible healthcare organizations and covered entities at significantly reduced prices.